The A.L.I.C.E. (ACrOmegalY PrImarY medICal treat-ment LearnIng and ImPrOVement WIth COntInUOUS MedICal EdUCatIOn) StUdY GrOUP COnVened In San GImIgnanO (SIena) frOm 6th tO 8th JUlY 2006 In Order tO dISCUSS the mOdern StrategY fOr the fIrSt-lIne theraPY Of neWlY dIagnOSed PatIentS WIth aCrOmegalY. The StUdY grOUP COnSIStS Of ClInICal endOCrInOlOgIStS and neUrOSUrgeOnS WIth exPerI¬enCe In ClInICal management Of PItUItarY dISeaSeS, aS detaIled belOW. The meetIng WaS OrganIZed WIth the aIm Of PrO¬VIdIng a dOCUment InClUdIng relIable CrIterIa UPOn WhICh a deCISIOn Of SeleCtIng a fIrSt-lIne medICal Or SUrgICal treatment In PatIentS WIth aCrOmegalY COUld be taKen. The dISCUSSIOn tOOK IntO COnSIderatIOn aS¬PeCtS related tO the CUrrent CUre CrIterIa, algOrIthmS Of treatment, effICaCY/tOlerabIlItY/COStS Of CUrrentlY aVaIlable medICal theraPIeS, effICaCY/COnSeqUenCeS/ COStS Of SUrgerY and radIOtheraPY aS fUnCtIOn Of mOSt mOdern teChnIqUeS. BelOW IS the SUmmarY Of the COnClUSIVe IndICatIOnS Shared WIthIn the grOUP.

Colao A., Martino E., Cappabianca P., Cozzi R., Scanarini M., Ghigo E., et al. (2006). First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 29(11), 1017-1020 [10.1007/BF03349217].

First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group

Arnaldi G.
Membro del Collaboration Group
;
2006-12-01

Abstract

The A.L.I.C.E. (ACrOmegalY PrImarY medICal treat-ment LearnIng and ImPrOVement WIth COntInUOUS MedICal EdUCatIOn) StUdY GrOUP COnVened In San GImIgnanO (SIena) frOm 6th tO 8th JUlY 2006 In Order tO dISCUSS the mOdern StrategY fOr the fIrSt-lIne theraPY Of neWlY dIagnOSed PatIentS WIth aCrOmegalY. The StUdY grOUP COnSIStS Of ClInICal endOCrInOlOgIStS and neUrOSUrgeOnS WIth exPerI¬enCe In ClInICal management Of PItUItarY dISeaSeS, aS detaIled belOW. The meetIng WaS OrganIZed WIth the aIm Of PrO¬VIdIng a dOCUment InClUdIng relIable CrIterIa UPOn WhICh a deCISIOn Of SeleCtIng a fIrSt-lIne medICal Or SUrgICal treatment In PatIentS WIth aCrOmegalY COUld be taKen. The dISCUSSIOn tOOK IntO COnSIderatIOn aS¬PeCtS related tO the CUrrent CUre CrIterIa, algOrIthmS Of treatment, effICaCY/tOlerabIlItY/COStS Of CUrrentlY aVaIlable medICal theraPIeS, effICaCY/COnSeqUenCeS/ COStS Of SUrgerY and radIOtheraPY aS fUnCtIOn Of mOSt mOdern teChnIqUeS. BelOW IS the SUmmarY Of the COnClUSIVe IndICatIOnS Shared WIthIn the grOUP.
dic-2006
Colao A., Martino E., Cappabianca P., Cozzi R., Scanarini M., Ghigo E., et al. (2006). First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 29(11), 1017-1020 [10.1007/BF03349217].
File in questo prodotto:
File Dimensione Formato  
BF03349217.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 91.11 kB
Formato Adobe PDF
91.11 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/638533
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 50
social impact